Circulating Bile Acids Profiles in Obese Children and Adolescents: A Possible Role of Sex, Puberty and Liver Steatosis.

NAFLD bile acids children endothelial function hypertension obesity steatosis

Journal

Diagnostics (Basel, Switzerland)
ISSN: 2075-4418
Titre abrégé: Diagnostics (Basel)
Pays: Switzerland
ID NLM: 101658402

Informations de publication

Date de publication:
20 Nov 2020
Historique:
received: 12 10 2020
revised: 11 11 2020
accepted: 18 11 2020
entrez: 25 11 2020
pubmed: 26 11 2020
medline: 26 11 2020
Statut: epublish

Résumé

Childhood obesity is becoming a major health issue and contributes to increasing the risk of cardiovascular disease in adulthood. Since dysregulated metabolism of bile acids (BAs) plays a role in progression of obesity-related disorders, including steatosis and hypertension, this study aimed to investigate BAs profiles in obese children with and without steatosis and hypertension, as well as exploring the interplay between BAs profile and vascular function. BAs concentrations were quantified with liquid chromatography-tandem mass spectrometry in 69 overweight/obese children and adolescents (mean age, 11.6 ± 2.5 years; 30 females). Liver steatosis was defined with abdomen ultrasonography, whilst hypertension was defined according to the current European guidelines. Vascular function was assessed with ultrasound technique, by measuring carotid intima media thickness (cIMT) and common carotid artery distensibility (cDC). Total and individual glycine-conjugated BAs concentrations were found to be significantly higher in males compared to females, as well as in pre-pubertal compared to pubertal stage ( The results suggest a possible role of BAs in the pathogenesis of liver and/or vascular damage in children and adolescent. Further studies are hence needed to validate these preliminary findings.

Sections du résumé

BACKGROUND BACKGROUND
Childhood obesity is becoming a major health issue and contributes to increasing the risk of cardiovascular disease in adulthood. Since dysregulated metabolism of bile acids (BAs) plays a role in progression of obesity-related disorders, including steatosis and hypertension, this study aimed to investigate BAs profiles in obese children with and without steatosis and hypertension, as well as exploring the interplay between BAs profile and vascular function.
METHODS METHODS
BAs concentrations were quantified with liquid chromatography-tandem mass spectrometry in 69 overweight/obese children and adolescents (mean age, 11.6 ± 2.5 years; 30 females). Liver steatosis was defined with abdomen ultrasonography, whilst hypertension was defined according to the current European guidelines. Vascular function was assessed with ultrasound technique, by measuring carotid intima media thickness (cIMT) and common carotid artery distensibility (cDC).
RESULTS RESULTS
Total and individual glycine-conjugated BAs concentrations were found to be significantly higher in males compared to females, as well as in pre-pubertal compared to pubertal stage (
CONCLUSION CONCLUSIONS
The results suggest a possible role of BAs in the pathogenesis of liver and/or vascular damage in children and adolescent. Further studies are hence needed to validate these preliminary findings.

Identifiants

pubmed: 33233601
pii: diagnostics10110977
doi: 10.3390/diagnostics10110977
pmc: PMC7699673
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

N Engl J Med. 2017 Jul 6;377(1):80-81
pubmed: 28604226
J Clin Invest. 2006 Apr;116(4):1102-9
pubmed: 16557297
Nutr Res Rev. 2020 Dec;33(2):271-286
pubmed: 32138805
J Pediatr Gastroenterol Nutr. 2015 Jul;61(1):85-90
pubmed: 25729888
Curr Opin Gastroenterol. 2014 May;30(3):332-8
pubmed: 24625896
Mol Metab. 2018 May;11:84-95
pubmed: 29656109
J Lipid Res. 2009 Oct;50(10):1955-66
pubmed: 19346330
Hepatology. 2018 Feb;67(2):534-548
pubmed: 28696585
Front Pharmacol. 2018 Dec 03;9:1382
pubmed: 30559664
PLoS One. 2018 Mar 7;13(3):e0193824
pubmed: 29513725
Hepatology. 2011 Sep 2;54(3):1082-1090
pubmed: 21618575
Hypertension. 2013 Sep;62(3):550-6
pubmed: 23817494
J Hypertens. 2002 Oct;20(10):1995-2007
pubmed: 12359978
Nat Rev Gastroenterol Hepatol. 2020 Mar;17(3):169-183
pubmed: 32015520
EMBO J. 2006 Apr 5;25(7):1419-25
pubmed: 16541101
Front Microbiol. 2018 Jun 05;9:1210
pubmed: 29922272
PLoS One. 2012;7(2):e32006
pubmed: 22359652
Science. 1999 May 21;284(5418):1362-5
pubmed: 10334992
Front Biosci. 1998 Feb 15;3:d176-93
pubmed: 9450986
Arterioscler Thromb Vasc Biol. 2007 Dec;27(12):2606-11
pubmed: 18029909
Med Sci Monit. 2001 May;7 Suppl 1:268-70
pubmed: 12211734
Biol Sex Differ. 2019 Nov 27;10(1):52
pubmed: 31775872
Ann Hepatol. 2017 Oct 28;16(Suppl. 1: s3-105.):s4-s14
pubmed: 29080336
Int J Obes Relat Metab Disord. 2004 Jan;28(1):159-66
pubmed: 14581934
J Clin Endocrinol Metab. 1998 Oct;83(10):3469-75
pubmed: 9768648
PLoS One. 2016 Apr 19;11(4):e0153959
pubmed: 27092559
Clin Transl Sci. 2011 Jun;4(3):210-8
pubmed: 21707953
Life Sci. 1988;42(19):1861-8
pubmed: 3367689
N Engl J Med. 2017 Jul 6;377(1):13-27
pubmed: 28604169
World J Gastroenterol. 2016 Sep 28;22(36):8078-93
pubmed: 27688650
Eur J Intern Med. 2014 Nov;25(9):795-802
pubmed: 25245607
Curr Opin Gastroenterol. 2005 May;21(3):344-7
pubmed: 15818156
Atherosclerosis. 2020 Jan;292:193-200
pubmed: 31811964
J Clin Endocrinol Metab. 2002 Jan;87(1):71-6
pubmed: 11788625
Dig Liver Dis. 2012 Apr;44(4):303-10
pubmed: 22169272
Atherosclerosis. 2012 Aug;223(2):372-7
pubmed: 22727194
Stroke. 2006 Jan;37(1):87-92
pubmed: 16339465
N Engl J Med. 1999 Jan 7;340(1):14-22
pubmed: 9878640
Br J Pharmacol. 1994 Aug;112(4):1209-15
pubmed: 7952883
Nat Rev Endocrinol. 2019 Dec;15(12):701-712
pubmed: 31616073
Gastroenterol Res Pract. 2015;2015:717431
pubmed: 25821461
N Engl J Med. 2005 Oct 27;353(17):1802-9
pubmed: 16251536
Am J Physiol. 1996 Dec;271(6 Pt 1):G1043-52
pubmed: 8997249
Clin Endocrinol (Oxf). 2011 Jan;74(1):67-72
pubmed: 21039722
J Pediatr Gastroenterol Nutr. 2011 Aug;53(2):190-5
pubmed: 21788761
Exp Clin Endocrinol Diabetes. 2017 Jan;125(1):28-32
pubmed: 27219878
Pediatr Clin North Am. 2011 Dec;58(6):1363-73, ix
pubmed: 22093856
Diagnostics (Basel). 2020 Aug 02;10(8):
pubmed: 32748848
Bull World Health Organ. 2007 Sep;85(9):660-7
pubmed: 18026621
Nitric Oxide. 2020 Jan 1;94:48-53
pubmed: 31669041
Gastroenterology. 2014 May;146(6):1525-33
pubmed: 24560870
J Hypertens. 2016 Oct;34(10):1887-920
pubmed: 27467768
Diagnostics (Basel). 2020 Jul 07;10(7):
pubmed: 32645999
J Clin Endocrinol Metab. 2020 Apr 1;105(4):
pubmed: 31825485
Pediatr Res. 1985 Mar;19(3):302-7
pubmed: 3982891
Clin Chem Lab Med. 2015 Oct;53(11):1807-13
pubmed: 25781695
Trends Microbiol. 2019 Dec;27(12):997-1010
pubmed: 31474424
Ultrasound Med Biol. 1997;23(2):157-64
pubmed: 9140173
J Gen Physiol. 2002 Mar;119(3):251-73
pubmed: 11865021
Am J Physiol Heart Circ Physiol. 2017 Jan 1;312(1):H21-H32
pubmed: 27765751
J Proteome Res. 2015 Nov 6;14(11):4844-50
pubmed: 26449593
Biochem Pharmacol. 2019 Mar;161:1-13
pubmed: 30582898
J Vasc Res. 2017;54(5):280-287
pubmed: 28930750
Eur Heart J. 2010 Jul;31(14):1745-51
pubmed: 20501481
World J Gastroenterol. 2009 Feb 21;15(7):804-16
pubmed: 19230041
Ital J Pediatr. 2018 Jul 31;44(1):88
pubmed: 30064525

Auteurs

Martina Montagnana (M)

Section of Clinical Biochemistry, Department of Neuroscience, Biomedicine and Movement Science, University of Verona, 37134 Verona, Italy.

Elisa Danese (E)

Section of Clinical Biochemistry, Department of Neuroscience, Biomedicine and Movement Science, University of Verona, 37134 Verona, Italy.

Alice Giontella (A)

"General Medicine and Hypertension" Unit, Department of Medicine, University of Verona, 37134 Verona, Italy.

Sara Bonafini (S)

"General Medicine and Hypertension" Unit, Department of Medicine, University of Verona, 37134 Verona, Italy.

Marco Benati (M)

Section of Clinical Biochemistry, Department of Neuroscience, Biomedicine and Movement Science, University of Verona, 37134 Verona, Italy.

Angela Tagetti (A)

"General Medicine and Hypertension" Unit, Department of Medicine, University of Verona, 37134 Verona, Italy.

Andrea Dalbeni (A)

"General Medicine and Hypertension" Unit, Department of Medicine, University of Verona, 37134 Verona, Italy.

Paolo Cavarzere (P)

Department of Surgery, Dentistry, Paediatrics and Gynaecology, University of Verona, 37126 Verona, Italy.

Rossella Gaudino (R)

Department of Surgery, Dentistry, Paediatrics and Gynaecology, University of Verona, 37126 Verona, Italy.

Mairi Pucci (M)

Section of Clinical Biochemistry, Department of Neuroscience, Biomedicine and Movement Science, University of Verona, 37134 Verona, Italy.

Gian Luca Salvagno (GL)

Section of Clinical Biochemistry, Department of Neuroscience, Biomedicine and Movement Science, University of Verona, 37134 Verona, Italy.

Franco Antoniazzi (F)

Department of Surgery, Dentistry, Paediatrics and Gynaecology, University of Verona, 37126 Verona, Italy.

Giuseppe Lippi (G)

Section of Clinical Biochemistry, Department of Neuroscience, Biomedicine and Movement Science, University of Verona, 37134 Verona, Italy.

Claudio Maffeis (C)

Department of Surgery, Dentistry, Paediatrics and Gynaecology, University of Verona, 37126 Verona, Italy.

Cristiano Fava (C)

"General Medicine and Hypertension" Unit, Department of Medicine, University of Verona, 37134 Verona, Italy.

Classifications MeSH